Publications

Year of Publication Titlesort descending Faculty Association
2011 Development of potent μ and δ opioid agonists with high lipophilicity. Yeon Sun Lee, Frank Porreca, PhD, Todd Vanderah, PhD
2008 Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells. George Watts, Ph.D.
2014 Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides.
2014 Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3ß and CDK5 following traumatic brain injury.
2012 Differential responses of progesterone receptor membrane component-1 (Pgrmc1) and the classical progesterone receptor (Pgr) to 17β-estradiol and progesterone in hippocampal subregions that support synaptic remodeling and neurogenesis. Roberta Diaz Brinton, Ph.D
2012 Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues. John M. Streicher, PhD
2015 Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands. Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2011 Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies. Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2014 Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cord. Victor Hruby, Ph.D., Josephine Lai , Ph.D., Yeon Sun Lee, Frank Porreca, PhD, Todd Vanderah, PhD
2015 Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain. Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2012 Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy. John M. Streicher, PhD
2016 Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain. Yeon Sun Lee, Frank Porreca, PhD
2013 Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists. Patrick W Mantyh, Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2002 Diverse actions of ovarian steroids in the serotonin neural system. John M. Streicher, PhD
2008 DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage. George Watts, Ph.D.
2014 Drug delivery to the ischemic brain. Patrick T Ronaldson, PhD
2016 Dynorphin A analogs for the treatment of chronic neuropathic pain. Yeon Sun Lee
2013 Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention. Roberta Diaz Brinton, Ph.D
2013 Early intervention with an estrogen receptor β-selective phytoestrogenic formulation prolongs survival, improves spatial recognition memory, and slows progression of amyloid pathology in a female mouse model of Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2017 Editorial: The Metabolic-Inflammatory Axis in Brain Aging and Neurodegeneration. Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D.
2013 Effect of anchoring 4-anilidopiperidines to opioid peptides. Victor Hruby, Ph.D., Josephine Lai , Ph.D., Yeon Sun Lee, Frank Porreca, PhD, Todd Vanderah, PhD
2016 Effect of Reproductive History and Exogenous Hormone Use on Cognitive Function in Mid- and Late Life. Roberta Diaz Brinton, Ph.D
2017 Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy. Nam Lee, Ph.D.
2015 Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. Frank Porreca, PhD, Todd Vanderah, PhD
2015 Endoglin Regulation of Smad2 Function Mediates Beclin1 Expression and Endothelial Autophagy. Nam Lee, Ph.D.

Pages